Eudaimonia Partners, LLC Novartis Ag Transaction History

Eudaimonia Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $59,668 - $65,905	-700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $39,829 - $46,970	-477 Reduced 40.53%	700 $60,000
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $6,160 - $6,825	-75 Reduced 5.99%	1,177 $102,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $12,301 - $13,847	-152 Reduced 10.83%	1,252 $109,000
Q1 2020 May 05, 2020	BUY	$70.67 - $99.01 $9,187 - $12,871	130 Added 10.2%	1,404 $116,000
Q4 2019 May 05, 2020	BUY	$84.35 - $95.37 $107,461 - $121,501	1,274 New	1,274 $121,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.